<scp>C</scp>ase <scp>R</scp>eport of <scp>E</scp>xtended “Temporary” Use of <scp>L</scp>evitronix <scp>CentriMag</scp> Right Ventricular Assist Device

Ortmann, Philipp; Saeed, Diyar; Lichtenberg, Artur

doi:10.1111/j.1525-1594.2012.01564.x

Cited by 3 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The implantation is technically challenging because of limited exposure of the pulmonary artery. Advantages may include possibility of early extubation, extended support duration, 8 and reduced risks of resternotomy at the time of RVAD explantation. The RVAD inflow cannula is inserted percutaneously through the right femoral vein.…”

Section: Resultsmentioning

confidence: 99%

Minimally Invasive Right Ventricular Assist Device Implantation in a Patient with HeartWare left ventricular Assist Device

Maxhera

Albert²,

Westenfeld³

et al. 2015

ASAIO Journal

Self Cite

View full text Add to dashboard Cite

Many centers reported positive outcome after left ventricular assist devices (LVADs) implantation using a minimally invasive approach. The main drawback of this minimally invasive approach is the feasibility of right ventricular assist device (RVAD) implantation with direct cannulation of the pulmonary artery in cases of perioperative right ventricular failure (RVF). We report our experience with a 41-year-old male patient who was supported with a temporary RVAD using J-sternotomy approach for RVF after LVAD implantation. No technical issue was encountered, and the patient's condition stabilized immediately after RVAD implantation. However, several days later, the patient developed severe septic shock caused by pneumonia and died on the postoperative day 15 after RVAD implantation.

show abstract

Section: Resultsmentioning

confidence: 99%

Minimally Invasive Right Ventricular Assist Device Implantation in a Patient with HeartWare left ventricular Assist Device

Maxhera

Albert²,

Westenfeld³

et al. 2015

ASAIO Journal

Self Cite

View full text Add to dashboard Cite

show abstract

“…The longest duration of support was in a 51-year-old patient with ischemic cardiomyopathy who underwent simultaneous LVAD/RVAD implantation, with transplantation performed after 88 days of support. 14 Eleven patients (52%), were successfully weaned from the RVAD, which was removed. Two patients were bridged directly to heart transplantation after 8 and 88 days of support, respectively.…”

Section: Txmentioning

confidence: 99%